Skip to content

Clinical trials

Phase 1 Neoplasms trials in Singapore

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 1 Country / region: Singapore Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20101
20111
20121
20133
20161
20172
20192
20201
20211
20222
20242
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Active, not recruiting4
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Novartis Pharmaceuticals3
Atavistik Bio, Inc1
Blueprint Medicines Corporation1
Boehringer Ingelheim1
Coherus Oncology, Inc.1
CytoMed Therapeutics Pte Ltd1
Hoffmann-La Roche1
Lantheus Biosciences Ltd.1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms21
Carcinoma, Non-Small-Cell Lung7
Colorectal Neoplasms4
Lung Neoplasms4
Triple Negative Breast Neoplasms4
Carcinoma, Renal Cell3
Colonic Neoplasms3
Intestinal Neoplasms3
Neoplasms by Site3
Ovarian Neoplasms3

Trials

Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.